NCT07395466Active, not recruiting
Improving Weight Loss in Healthy Adults With Overweight and Obesity: An Artificial Intelligence-assisted Dietary Prediction and Prevention System With Continuous Glucose Monitoring
Source: ClinicalTrials.gov · Last updated 9 Feb 2026
Brief summary (registry, in English)
This study aims to examine the effectiveness of a novel dietary lapse prediction and prevention self-regulation app called the eating behaviour trigger-response inhibition program (eTRIP), and the addition of continuous glucose monitoring (CGM), on healthy eating and weight loss in people with overweight and obesity.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 24 Jun 2025
- Start date
- 22 Jan 2025
- Primary completion date
- Jul 2026
- Lead sponsor
- National University Health System, Singapore
- Diseases
- Obesity
- NCT number
- NCT07395466
What you commit to
- Study type: Interventional
- Planned participants: 300
- From 22 Jan 2025 to the primary completion date, Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- are scheduled for any kind of surgery within the next 6 months
Other illness
- are diagnosed severe mental disorders (e.g. major depressive disorder and schizophrenia)
- have serious medical conditions
Other
- are using/intend to use other apps for weight loss;
- are pregnant or lactating (as it would affect weight change and caloric needs)
- are on prescribed meal replacements or pharmacotherapy
Who the study is looking for
- are 21-65 years old
- have BMI ≥23 kg/m2
- can comprehend the English language
- uses a smartphone that can download apps
- are willing to perform continuous glucose monitoring (CGM) using the Dexcom continuous glucose monitoring system
- willing to travel to the National University of Singapore (NUS)
- able to provide informed consent
Age in the registry: 21 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National University of Singapore Coordinator of this site? Confirm its status | Singapore | Singapore | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.